» Articles » PMID: 2198396

Hepatic Cyst Infection in Autosomal Dominant Polycystic Kidney Disease

Overview
Journal Mayo Clin Proc
Specialty General Medicine
Date 1990 Jul 1
PMID 2198396
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

To characterize the syndrome of hepatic cyst infection in autosomal dominant polycystic kidney disease (ADPKD) and to review its diagnosis and management, we retrospectively studied five such cases in patients from our institution and nine detailed case reports from the literature. The clinical manifestations were an acute (58%) or subacute (42%) febrile illness, typically associated with tenderness in the right upper quadrant, leukocytosis, a very high erythrocyte sedimentation rate, but minor abnormalities of liver function tests. Bacteremia was present in 7 of 11 patients. Enterobacteriaceae grew in pure culture from the cyst fluid in 9 of 12 patients. Complex cysts were observed by ultrasonography (in four of eight patients), computed tomography (in six of nine), and magnetic resonance imaging (in two of two). 111In leukocyte scans were positive in all four patients in whom they were done, and 67Ga scans were positive in only one of three patients. An unfavorable outcome was observed in six of seven patients treated with only antibiotics, in contrast with one of seven patients who received antibiotics and early drainage. In two patients, ciprofloxacin cyst levels were 2.3 and 4.8 times higher than the level in serum; in a third patient, cyst levels remained in therapeutic range 30 hours after the last dose of ciprofloxacin, at which time serum levels were undetectable. Clinical and laboratory features and the use of modern scanning techniques facilitate a prompt diagnosis of infection in hepatic cysts in ADPKD. The treatment of choice is a combination of percutaneous drainage and antimicrobial therapy.

Citing Articles

Liver cyst penetration of antibiotics at the target site of infection: a randomized pharmacokinetic trial.

Bernts L, Bruggemann R, Jansen A, Jager N, Wertheim H, Drenth J J Antimicrob Chemother. 2024; 80(1):182-191.

PMID: 39508371 PMC: 11695873. DOI: 10.1093/jac/dkae394.


Polycystic intrahepatic infection caused by Enterococcus casseliflavus: a case report and literature review.

Xu S, Huang B, Cao Y, Zhong Z, Yin J BMC Nephrol. 2024; 25(1):88.

PMID: 38448824 PMC: 10919048. DOI: 10.1186/s12882-024-03531-z.


Pathology of Fibropolycystic Liver Diseases.

Lewis J Clin Liver Dis (Hoboken). 2021; 17(4):238-243.

PMID: 33968382 PMC: 8087910. DOI: 10.1002/cld.1044.


Candida albicans and Staphylococcus lugdunensis superinfection of liver cysts in a patient with autosomal dominant polycystic kidney disease under prednisolone treatment.

Iijima T, Suwabe T, Inui K, Mizuno H, Hiramatsu R, Yamanouchi M CEN Case Rep. 2020; 9(4):370-374.

PMID: 32440858 PMC: 7502095. DOI: 10.1007/s13730-020-00488-4.


Autosomal dominant polycystic kidney disease: updated perspectives.

Rastogi A, Ameen K, Al-Baghdadi M, Shaffer K, Nobakht N, Kamgar M Ther Clin Risk Manag. 2019; 15:1041-1052.

PMID: 31692482 PMC: 6716585. DOI: 10.2147/TCRM.S196244.